BrainAurora Medical Technology First Half 2025 Earnings: CN¥0.11 loss per share (vs CN¥0.13 loss in 1H 2024)

Simply Wall St·09/01/2025 01:18:16

Listen to the news

BrainAurora Medical Technology (HKG:6681) First Half 2025 Results

Key Financial Results

Revenue: CN¥100.1m (up 93% from 1H 2024).
Net loss: CN¥126.4m (loss widened by 11% from 1H 2024).
CN¥0.11 loss per share.

We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

earnings-and-revenue-growth — SEHK:6681 Earnings and Revenue Growth September 1st 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

BrainAurora Medical Technology Earnings Insights

Looking ahead, revenue is forecast to grow 37% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Healthcare Services industry in Asia.

Performance of the market in Hong Kong.

The company's share price is broadly unchanged from a week ago.

Risk Analysis

Be aware that BrainAurora Medical Technology is showing 1 warning sign in our investment analysis that you should know about...

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Contact Number : +852 3852 8500

Monday 7:00 AM - Saturday 9:00 AM (HKT)

Service Email : service@webull.hk

Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)

Business Cooperation : marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English